APA (7th ed.) Citation

Zhang, Z., Sehgal, K., Shirai, K., Butler, R. A., Wiencke, J. K., Koestler, D. C., . . . Christensen, B. C. Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapy. Nature Portfolio.

Chicago Style (17th ed.) Citation

Zhang, Ze, et al. Methylation Cytometric Pretreatment Blood Immune Profiles with Tumor Mutation Burden as Prognostic Indicators for Survival Outcomes in Head and Neck Cancer Patients on Anti-PD-1 Therapy. Nature Portfolio.

MLA (9th ed.) Citation

Zhang, Ze, et al. Methylation Cytometric Pretreatment Blood Immune Profiles with Tumor Mutation Burden as Prognostic Indicators for Survival Outcomes in Head and Neck Cancer Patients on Anti-PD-1 Therapy. Nature Portfolio.